Abstract
Introduction:
Acne scarring is a very common problem, which can be extensive, and may lead to significant psychosocial morbidity. Multiple types of treatments are used to ameliorate atrophic scars with varying degrees of success. This paper provides an overview of the various energy-based modalities that are commonly employed against acne scarring.
Objectives and methods:
A comprehensive literature search of papers published since 2008 was performed in order to determine the efficacy and adverse reactions of commonly used energy-based treatments against post-acne scarring.
Results:
A total of 59 relevant articles were identified covering a multitude of different devices.
Discussion:
Ablative lasers seem to achieve the highest degree of efficacy, albeit this is associated with significant pain and downtime, and the risk for long-term pigmentary changes. Non-ablative fractional photothermolysis (FP) has a much safer profile but cannot achieve as good cosmetic results. The efficacies of fractional radiofrequency microneedling and radiofrequency are slightly inferior to that of FP but offer an even safer adverse profile. Little evidence is available on the remaining devices, with larger studies required in order to reach more solid conclusions.
Conclusion:
Multiple devices have been used with varying levels of efficacy and very different safety profiles. There is an overall lack of high-quality evidence about the effects of different interventions. Furthermore, no standardised scale is available for acne scarring, leading to variability in evaluation and interpretation of data in different studies.
Keywords: Ablative, acne scarring, energy devices, lasers, non-ablative, photothermolysis, radiofrequency
Introduction
Scarring is the main complication of acne and arises from the disorganised production and deposition of collagen around inflamed follicles, resulting in visibly depressed scars.1 Such scarring is very common and can lead to impairment in quality of life, as well as being a risk factor for depression and even suicide. Furthermore, it has been linked to poor self-esteem, anxiety and lowered academic performance.2
Despite the wide array of methods available to improve the appearance of acne scarring, no ‘gold standard’ modality has emerged to date that will clear such scars completely and consistently. Newer treatments and the combination of multiple modalities could therefore be key in achieving consistent results in a large percentage of patients, even in those with severe scarring.
Therapeutic interventions can be generally split into energy- and non-energy-based techniques.
Commonly employed non-energy-based methods include chemical peels, subcision, microneedling, dermabrasion and tissue augmentation with a variety of fillers. These have been covered in part 1 of this literature review.3
Energy-based modalities can be further divided into light-based modalities, lasers and radiofrequency devices.
Lasers are the commonest employed modality and come in different types. Traditionally, ablative lasers were widely used in the past due to their ability to produce good cosmetic results after only one treatment.4 Ablative methods work by removing the epidermis and part of the dermis on the affected areas, leading to subsequent neocollagenesis and remodelling;5 however, the association of the ablative lasers with extended recovery periods and other untoward side effects has led to the increasing use of the safer fractional and non-ablative technologies.4
Unlike traditional ablative means, fractional ablative lasers utilise regularly spaced arrays over a fraction of the skin surface. These induce thermal ablation in microscopic columns of epidermal and dermal tissue while sparing the remaining skin. This approach leads to significantly faster recovery times when compared to traditional ablative resurfacing.6
Non-ablative lasers, on the other hand, are able to cause thermal injury in the dermis while preserving the epidermis from any ablation. This process is known as fractional photothermolysis (FP) and limits side effects and recovery time even further.7
With radiofrequency (RF) devices, electrical current flows through the skin between the electrode-pin rows generating deep dermal heating. This in turn induces skin injury eliciting a healing response and stimulating the remodelling of dermal collagen.8
The microneedling RF (MRF) method consists of multiple needles that enable the delivery of RF directly to the dermis. The needles are insulated to prevent electrothermal damage from occurring anywhere but at the very tip of the needle and never in the epidermis, which undergoes purely mechanical needling. In contrast to ablative and non-ablative lasers, treatment with MRF can be controlled by varying the depth of the needles, thus allowing for discrete electrothermal coagulation at different levels of the dermis.9,10
Objectives and methods
The aim of this paper is to provide with an overview of the most up-to-date energy-based treatments used in acne scarring.
A comprehensive literature search of papers published since 2008 was performed on PubMed. A search using the keywords [(scar(s), scarring) AND (acne)] was utilised. Only original articles written in English were included. Individual case reports were excluded. Following screening of abstracts, a total of 59 relevant articles were selected.
Results
A total of 59 relevant articles were included in this review. These have been categorised according to research methodology and modality.
Randomised controlled trials
Twenty-three randomised controlled trials (RCTs) were identified (Table 1).
Table 1.
A synopsis of all randomised controlled trials.
| Authors | Publication year | Patients (n) | Level of evidence* | Treatment method | Cosmetic outcome | Adverse effects |
|---|---|---|---|---|---|---|
| Ahmed et al. | 2014 | 28 | 1.c | CO2 laser pinpoint irradiation (Group 1) vs. TCA CROSS (Group 2) | CO2 laser pinpoint irradiation is more effective than TCA CROSS | CO2 laser group: pustules and hyperpigmentation; TCA CROSS group: itching, infection and hyperpigmentation |
| Alexis et al. | 2016 | 7 | 1.d | Low-energy (Group 1) vs. high-energy (Group 2) non-ablative fractional Er:Glass laser | Mean improvement in scarring was measured as ‘significantly improved’; no statistically significant difference was found between the two groups | Both groups: pain, erythema, oedema, bleeding, hyperpigmentation and hypopigmentation |
| Bjørn et al. | 2013 | 11 | 1.d | Fractional CO2 laser at 1-month intervals (Group 1) vs. at 3-month intervals (Group 2) | Scarring improved from a mean value of 5.86 ± 1.87 to: • Group 1: 1.56 ± 1.24 • Group 2: 1.33 ± 1.66 (Based on a 10-point scoring method) |
Pain, oozing, bleeding, oedema, erythema, hypopigmentation and hyperpigmentation |
| Cachafeiro et al. | 2016 | 42 | 1.c | Non-ablative fractional Er:Glass laser (Group 1) vs. microneedling (Group 2) | Group 1: mean improvement of 3.41; Group 2: mean improvement of 4.05 (based on the Quantitative Global Grading System) | Both groups: pain, erythema, hyperpigmentation, crusting, pustules and bullae |
| Chae et al. | 2015 | 40 | 1.c | Non-ablative fractional Er:Glass laser (Group 1) vs. FRM (Group 2) | Overall scar improvement: Group 1: none - 1 patient, slight - 3 patients, average - 5 patients, good - 8 patients, and excellent - 3 patients; Group 2: none - 2 patients, slight - 5 patients, average - 5 patients, good - 7 patients, and excellent - 1 patient |
Both groups: pain, erythema, oedema, acneiform eruptions, dryness and hyperpigmentation |
| Cho et al. | 2010 | 8 | 1.c | Non-ablative fractional Er-Glass laser (Group 1) vs. ablative fractional CO2 laser (Group 2) | Group 1: 1 patient had no improvement, 6 patients improved by 26–50%, and 1 by 51–75% Group 2: 5 patients improved by 26–50%, 2 patients by 51–75%, and 1 by > 76% |
Both groups: pain, crusting, erythema, oedema, hyperpigmentation, bleeding, oozing and aggravation of active acne lesions |
| Faghihi et al. | 2015 | 42 | 1.c | Punch elevation plus fractional CO2 laser resurfacing (Group 1) vs. isolated CO2 laser resurfacing (Group 2) | Group 1: minimal response in 21.4%, moderate 42.9%, good 35.7%, excellent 0%; Group 2: minimal response 26.2%, moderate 42.9%, good 31%, excellent 0% | Both groups: erythema, crusting, burning, hyperpigmentation, pain, oedema, discharge and pruritus |
| Faghihi et al. | 2016 | 16 | 1.c | Ablative fractional CO2 laser plus intradermal PRP (Group 1) vs. ablative fractional CO2 laser plus intradermal normal saline (Group 2) | Group 1: no or little response in 12.5%, fair or good in 87.5%, excellent in 0%; Group 2: no or little response in 31.2%, fair or good in 68.8%, excellent response in 0% | Both groups: erythema and oedema |
| Gawdat et al. | 2013 | 30 | 1.c | Fractional ablative CO2 laser and intradermal PRP (Group 1) vs. fractional ablative CO2 laser and intradermal saline (Group 2) vs. fractional ablative CO2 laser and topical PRP (Group 3) | Group 1: excellent improvement achieved in 66.7%; Group 2: excellent improvement achieved in 26.7%; Group 3: excellent improvement achieved in 60% | All groups: pain, erythema, oedema, crusting and hyperpigmentation |
| Hedelund et al. | 2012 | 12 | 1.c | Fractional CO2 laser vs. untreated control | Mean pre-treatment scar texture 6.15 ± 1.23 and atrophy 5.72 ± 1.45 scoring; post-treatment scar texture 3.89 ± 1.7 and atrophy 3.56 ± 1.76 scoring (based on a 10-point scoring method) | Pain and erythema |
| Kim et al. | 2009 | 20 | 1.d | High- (Group 1) vs. low-energy ablative fractional CO2 laser (Group 2) vs. low-energy CO2 laser combined with non-ablative Nd:YAG laser (Group 3) | Group 1: 2 patients had 30–49% improvement and 8 had 50–69%; Group 2: 7 patients had 10–39% improvement and 3 had 40–59%; Group 3: 1 patient had 40–49% improvement, 7 had 50–59%, 9 had 50–69% and three had 60–69% | All groups: erythema, crusting and hyperpigmentation |
| Kim et al. | 2009 | 18 | 1.c | Non-ablative fractional Er:Glass laser (Group 1) vs. TCA CROSS (Group 2) | Group 1: average scarring improvement of 2.51; Group 2: average scarring improvement of 2.44 (based on a 4-point scoring method) | Both groups: pain and erythema |
| Leheta et al. | 2012 | 39 | 1.c | PCI combined with 20% TCA (Group 1) vs. non-ablative fractional Er:Glass laser (Group 2) vs. PCI and Er:Glass laser (Group 3) | Group 1: 59.79% improvement in scarring; Group 2: 61.83% improvement; Group 3: 78.27% improvement | All groups: pain, erythema, oedema and desquamation |
| Mahmoud et al. | 2010 | 15 | 1.d | 10mJ (Group 1) vs. 40mJ (Group 2) fractional Er:YAG laser | Average scar improvement of 1.2 (Group 1) and 1.4 (Group 2) (based on a 4-point scoring method) | Both groups: pain, erythema, hyperpigmentation and urticarial eruptions |
| Min et al. | 2015 | 20 | 1.c | FRM (Group 1) vs. bipolar RF (Group 2) | FMR was more effective than BR, especially in ice-pick and boxcar scars; scarring decreased by 65% on the FMR-treated side | Both groups: erythema |
| Min et al. | 2009 | 19 | 1.c | Non-ablative Nd:YAG laser (Group 1) vs. combined Nd:YAG and PDL lasers (Group 2) | Group 1: 27% improvement in scarring; Group 2: 32.3% improvement. Both modalities were effective at treating superficial rolling and boxcar scars but ineffective at treating deep and ice-pick scars | Both groups: pain, erythema and oedema |
| Min et al. | 2016 | 24 | 1.c | Ablative fractional Er:YAG laser (Group 1) vs. bipolar RF combined with non-ablative infrared diode laser (Group 2) | Group 1: 50% mean improvement in scarring; Group 2: 25% mean improvement | Group 1: pain, oozing and crusting; Group 2: erythema |
| Phothong et al. | 2016 | 30 | 1.d | High energy (Group 1) vs. moderate energy bipolar fractional RF (Group 2) | Scar appearance was significantly reduced in both groups. Group 1 demonstrated enhanced improvement in appearance | Both groups: pain, erythema and hyperpigmentation |
| Ronsgaard et al. | 2014 | 20 | 1.c | Fractional bipolar RF (Group 1) vs. non-ablative fractional Er:Glass laser (Group 2) | Group 1: mean improvement of 2.70 ± 0.37; Group 2: mean improvement of 2.86 ± 0.42 (based on a 4-point scoring method) | Both groups: pain, erythema, dryness and crusting |
| Wanitphakdeedecha et al. | 2009 | 24 | 1.d | 300 μs (Group 1) vs. 1500 μs (Group 2) of ablative variable square pulse Er:YAG laser | Group 1: 72.7% of patients achieved > 50% improvement; Group 2: 63.6% of patients achieved > 50% improvement | Both groups: hyperpigmentation and acneiform eruptions |
| Yang et al. | 2016 | 30 | 1.c | Non-ablative fractional Er:Glass laser (Group 1) vs. asiaticoside cream (Group 2) | Group 1: mean improvement of 5.65 ± 4.34 (P < 0.0001); Group 2: mean improvement of 1.23 ± 3.41 (P < 0.0938) (based on a 4-point scoring method) | Group 1: hyperpigmentation; Group 2: none |
| Yuan et al. | 2014 | 20 | 1.d | Fractional CO2 laser 20 mJ, 10% density (Group 1) vs. 20 mJ, 20% density (Group 2) vs. 10 mJ, 10% density (Group 3) | Group 1: 35% achieved marked improvement, 45% moderate and 20% minimal; Group 2: 50% achieved marked improvement, 30% moderate and 20% minimal Group 3: 20% achieved marked improvement, 60% moderate, and 20% minimal improvement (<25% minimal improvement, 26-50% moderate, 51-75% marked, and >75% near total) |
All groups: pain, bleeding, oozing, oedema, crusting, erythema, pruritus, dryness and hyperpigmentation; Groups 1 and 2: acneiform eruptions |
| Zhang et al. | 2013 | 33 | 1.c | Fractional microplasma RF (Group 1) vs. fractional CO2 laser (Group 2) | Group 1: scarring improved by a mean of 56.4%; Group 2: scarring improved by a mean of 59.2% | Both groups: pain, crusting, erythema and hyperpigmentation |
Joanna Briggs Institute classification.
CO2 laser
Ten papers focused on the efficacy of the CO2 laser. In the largest RCT in this group (42 patients), Faghihi et al. compared treatment with punch elevation alongside fractional CO2 laser resurfacing (21.4% minimal response, 42.9% moderate, 35.7% good) against that of isolated CO2 laser resurfacing (26.2% minimal response, 42.9% moderate, 31% good).11
In other large trials, Zhang et al. (33 patients) compared fractional microplasma radiofrequency (RF) (56.4% mean improvement) to the fractional ablative CO2 laser (59.2%).12
Gawdat et al. (30 patients) assessed the efficacy of the fractional ablative CO2 laser combined with either saline (excellent improvement in 26.7%), intradermal platelet rich plasma (PRP) (excellent improvement in 66.7%) or topical PRP (excellent improvement in 60%).13
Ahmed et al. (28 patients) found the efficacy of CO2 laser pinpoint irradiation to be superior to that of chemical peeling (trichloroacetic acid chemical reconstruction of skin scars – TCA CROSS technique).14
One study (16 patients) studied the effects of the ablative fractional CO2 laser either in isolation (31.2% little or no response, 68.8% fair or good response) or alongside with intradermal PRP (12.5% little or no response, 87.5% fair or good response).15 Another study (12 patients) achieved good improvement in scar texture and atrophy with the ablative fractional CO2 laser.7 Compared to the non-ablative fractional Er-Glass laser, Cho et al. (eight patients) achieved slightly superior results with the ablative fractional CO2 laser.16
Kim et al. (20 patients) assessed the response of high-energy (two patients had 30–49% improvement and eight had 50–69% improvement) and low-energy (seven patients had 10–39% improvement and three had 40–59% improvement) ablative fractional CO2 laser resurfacing as well as that of fractional ablative CO2 laser resurfacing combined with non-ablative Nd:YAG resurfacing (one patient had 40–49% improvement, seven had 50–59% improvement, nine had 50–69% improvement and three had 60–69%).17
Yuan et al. (20 patients) reviewed the effects of three different energy and density settings of the fractional CO2 laser (20mJ, 10% vs. 20mJ, 20% vs. 10mJ, 10%). Results were comparable across all three groups, but with somewhat efficacy in the higher-energy higher-density group.18
Finally, Bjørn et al. (11 patients) assessed the response of acne scars to treatment with the fractional CO2 laser at either one- or three-month intervals.19 Results were significant in efficacy and comparable across both groups.
Er:Glass fractional photothermolysis
Seven RCTs were included in this category.
Cachafeiro et al. (42 patients) compared Er:Glass laser to microneedling (mean improvement of 3.41% and 4.05%, respectively),2 and Ronsgaard et al. (20 patients) compared Er:Glass to bipolar RF (mean improvement of 2.86% ± 0.42 and 2.70% ± 0.37, respectively).8
Another study (40 patients) reported moderate but slightly superior results with the Er:Glass against those achieved with fractional radiofrequency microneedling (FRM).1
One study (39 patients) compared isolated Er:Glass FP (59.79% improvement) to that of FP plus percutaneous collagen induction (PCI) (61.83% improvement) and also against PCI plus 20% TCA (78.27% improvement).20
Kim et al. (18 patients) compared the Er:Glass laser to the TCA CROSS method (average improvement of 2.51% and 2.44%, respectively)21 and Yang et al. (30 patients) compared it to asiaticoside cream (mean improvement of 5.65% ± 4.34 and 1.23% ± 3.41, respectively).22
The final study in this category (seven patients) reported significant and comparable improvement in appearance, with both high- and low-energy levels of Er:Glass photothermolysis.23
Er:YAG fractional photothermolysis
Three studies utilised this modality.
Min et al. (24 patients) displayed superior efficacy with the Er:YAG laser (50% mean improvement) compared to the combination of bipolar RF and the non-ablative infrared diode laser (25% mean improvement).24
Mahmoud et al. (15 patients) attained mild improvement with both 10-mJ and 40-mJ energy settings of the Er:YAG laser.25 Wanitphakdeedecha et al. (24 patients), on the other hand, found that 72.7% of patients achieved > 50% improvement with the 300-ms wavelength, whereas only 63.6% achieved > 50% improvement with the 1500-ms wavelength.26
Other modalities
The remaining RCTs studied a mixture of energy devices.
Min et al. (20 patients) assessed the efficacy of FRM against that of bipolar RF and found FMR to be superior, especially against ice-pick and boxcar scars.27
In a different paper, Min et al. (19 patients) studied the effects of treatment with the long-pulse Nd:YAG laser either in isolation (27% improvement) or in combination to the PDL laser (32.3% improvement).28 Both modalities were found to be effective at treating superficial rolling and boxcar scars but ineffective at treating deep and ice-pick scars.
Finally, one study (30 patients) compared high- to moderate-energy bipolar fractional RF.29 Scar appearance was significantly reduced in both groups but high-energy settings demonstrated superior efficacy.
Non-randomised controlled trials
Two non-RCTs were identified (Table 2).
Table 2.
A synopsis of all non-RCTs.
| Authors | Publication year | Patients (n) | Level of evidence* | Treatment method | Cosmetic outcome | Adverse effects |
|---|---|---|---|---|---|---|
| Cameli et al. | 2014 | 6 | 2.c | Fractional CO2 laser plus RF (Group 1) vs. fractional CO2 laser in isolation (Group 2) | Group 1: 50% achieved excellent, and 50%, good scar improvement; Group 2: 30% achieved excellent, 40% good, and 30% sufficient scar improvement | Both groups: burning, erythema and oedema |
| Uebelhoer et al. | 2007 | 6 | 2.c | Single pass of stacked double pulses (Group 1) vs. double pass of single pulses (Group 2) of non-ablative diode laser | Both groups: mean improvement in scar appearance of < 1 (based on a 3-point scoring method) | Both groups: erythema, oedema, burning and hyperpigmentation |
Joanna Briggs Institute classification.
In a study of six patients, Cameli et al. compared treatment with fractional CO2 laser plus RF (50% achieved excellent and 50% good scar improvement) against that of fractional CO2 laser in isolation (30% achieved excellent, 40% good and 30% sufficient scar improvement).30
Uebelhoer et al. treated six patients with the non-ablative diode laser, either with a single pass of stacked double pulses or with a double pass of single pulses.31 In both groups, mean improvement in scar appearance was minimal.
Retrospective studies
Four papers were included in this category (Table 3).
Table 3.
A synopsis of all retrospective studies.
| Authors | Publication year | Patients (n) | Level of evidence* | Treatment method | Cosmetic outcome | Adverse effects |
|---|---|---|---|---|---|---|
| Alajlan et al. | 2011 | 82 | 2.d | Non-ablative fractional Er:Glass laser (Group 1) vs. ablative fractional CO2 laser (Group 2) | Group 1: 77% attained > 25% improvement and 35% > 50%; Group 2: 70% attained > 25% improvement, and 37% > 50% | Groups 1 and 2: hyperpigmentation, acneiform eruptions, herpes reactivation; Group 2: hypopigmentation and erythema |
| Badawi et al. | 2011 | 22 | 2.d | Non-ablative Nd:YAG laser | Median improvement of 2 (based on a 3-point scale) | Erythema and oedema |
| Chan et al. | 2011 | 47 | 2.d | Full (Group 1) vs. mini (Group 2) non-ablative fractional Er:Glass laser | Group 1: mild improvement in 23.1%, moderate in 7.7%, good in 15.4%, excellent in 53.8%; Group 2: mild improvement in 0%, moderate in 13.3%, good in 40%, excellent in 46.7% | Both groups: oedema and hyperpigmentation |
| Kim et al. | 2014 | 20 | 2.d | Ablative fractional CO2 laser | Almost all patients achieved moderate improvement | Pain, erythema and crusting |
Joanna Briggs Institute classification.
Alajlan et al. compared the efficacy of the non-ablative Er-doped fractional laser (77% attained > 25% improvement and 35% attained > 50% improvement) against that of fractional ablative CO2 laser (70% attained > 25% improvement and 37% attained > 50% improvement).34
Chan et al. assessed the effects of the non-ablative fractional Er-doped fibre laser by comparing full (mild improvement in 23.1%, moderate in 7.7%, good in 15.4%, excellent in 53.8%) against mini resurfacing (mild improvement in 0%, moderate in 13.3%, good in 40%, excellent in 46.7%).33
Using the fractional ablative CO2 laser, Kim et al. achieved moderate improvement in appearance across the vast majority of patients,34 whereas with the use of the non-ablative Nd:YAG laser Badawi et al. achieved moderate results.35
Observational studies
A total of 30 observational studies have been included in this review article, which are summarised in Table 4.9,10,36–63
Table 4.
A synopsis of all observational studies.
| Authors | Publication year | Patients (n) | Level of evidence* | Treatment method | Cosmetic outcome | Adverse effects |
|---|---|---|---|---|---|---|
| Bencini et al. | 2012 | 87 | 2.d | Non-ablative fractional Er:Glass laser | 8% showed moderate improvement and 92% marked improvement | Pain, erythema, oedema, acneiform eruption, hyperpigmentation |
| Brauer et al. | 2016 | 20 | 2.d | Picosecond laser with diffractive lens | Mean improvement in scar appearance of 1.4 (based on a 3-point scoring method) | Pain, erythema and oedema |
| Chan et al. | 2011 | 47 | 2.d | Full (Group 1) vs. mini (Group 2) non-ablative fractional erbium laser | Group 1: mild improvement in 23.1%, moderate in 7.7%, good in 15.4%, excellent in 53.8%; Group 2: mild improvement in 0%, moderate in 13.3%, good in 40%, excellent in 46.7% | Both groups: oedema and hyperpigmentation |
| Chandrashekar et al. | 2014 | 31 | 2.d | FRM | Grade 3 scars: 76.47% improved by 2 grades; Grade 4 scars: 85.71% improved by 2 grades; Rolling and boxcar scars showed better response than ice-pick scars (based on the Qualitative Global Scarring Grading System) | Pain, erythema, oedema, hyperpigmentation and track marks |
| Chapas et al. | 2008 | 13 | 2.d | Ablative fractional CO2 laser resurfacing | Mean scar improvement of 66.8% | Erythema, oedema, petechiae, oozing, crusting and hyperpigmentation |
| Cho et al. | 2009 | 12 | 2.d | Non-ablative fractional Er:Glass laser | Mean improvement of 2.8 (based on a 4-point scoring system) | Pain, erythema and oedema |
| Chrastil et al. | 2008 | 29 | 2.d | Non-ablative fractional erbium laser | 5 patients achieved > 75% improvement, 18 achieved 50–75%, 5 achieved 25–50%, and 1 achieved < 25% improvement | Discomfort, erythema and oedema |
| Engin et al. | 2012 | 21 | 2.d | Ablative Er:YAG laser | Near total improvement in 19%, good in 57% and fair in 24% | Erythema, crusting, oozing and aggravation of active acne lesions |
| Gonzalez et al. | 2008 | 9 | 2.d | Plasma skin regeneration system | Mean improvement of 34.4% | Pain, pruritus, erythema, hyperpigmentation and herpetic lesions |
| Hu et al. | 2011 | 34 | 2.d | Ablative fractional Er:YAG laser | Good to excellent improvement in 63.6% and fair improvement in 36.4% | Erythema, oedema, crusting and hyperpigmentation |
| Hwang et al. | 2012 | 10 | 2.d | Fractional CO2 laser resurfacing | Overall scar improvement of 2.9 (based on a 4-point scoring method) | Pain, pinpoint bleeding, erythema, oozing, crusting, oedema and hyperpigmentation |
| Keller et al. | 2007 | 12 | 2.d | Non-ablative Nd:YAG laser | Mild to moderate clinical improvement was observed in most patients | Pain, burning, scarring and hyperpigmentation |
| Kim et al. | 2011 | 20 | 2.d | Ablative fractional YSGG laser | Fourteen patients had 60–90% improvement and six had 40–59% improvement | Erythema |
| Majid et al. | 2014 | 60 | 2.d | Fractional CO2 laser resurfacing | Excellent response was observed in 43.3%, good in 25% and poor in 31.7%; Rolling and superficial boxcar scars responded the best and ice-pick scars responded the least | Erythema, crusting, oedema, acneiform eruption and hyperpigmentation |
| Nirmal et al. | 2013 | 25 | 2.d | Ablative fractional Er:YAG laser | 96% of patients showed at least fair improvement; Rolling and superficial boxcar scars showed significantly higher improvement compared to ice-pick and deep boxcar scars | Crusting, hyperpigmentation, acneiform eruptions and erythema |
| Omi et al. | 2011 | 7 | 2.d | Fractional CO2 laser | Some improvement in scarring was observed in all patients | Erythema |
| Park et al. | 2015 | 20 | 2.d | Fractional RF and sublative fractional RF | Mean improvement in rolling scars 3.3, boxcar scars 2.7, and ice-pick scars 1.8 (based on a 4-point scoring system) | Pain, crusting, erythema, flushing, oozing, hyperpigmentation and aggravation of acne |
| Peterson et al. | 2011 | 15 | 2.d | Combined RF and fractionated RF | Mean scar severity decreased by 72.3% | Discomfort |
| Petrov et al. | 2016 | 40 | 2.d | Fractional CO2 laser | Average scores pre and post treatment: • Ice-pick: from 3.46 to 1.86 • Rolling: from 4.1 to 2.37 • Boxcar: from 3.5 to 1.9 (based on a 4-point scoring method) |
Erythema, oedema, prickling sensation and hyperpigmentation |
| Ramesh et al. | 2010 | 30 | 2.d | Matrix-tunable RF | 4 patients achieved > 60% improvement; 18 patients achieved 35–60% improvement; 8 patients achieved < 35% improvement | Burning and erythema |
| Sardana et al. | 2014 | 35 | 2.d | Non-ablative fractional Er:Glass laser | Boxcar scars: mean improvement of 52.9%; Rolling scars: mean improvement of 43.1%; Ice-pick scars: mean improvement of 25.9% | Erythema, oedema, pain, acneiform eruptions, dryness and hyperpigmentation |
| Taub et al. | 2011 | 20 | 2.d | Sublative fractional bipolar RF combined with non-ablative diode laser | Significant improvement in scar appearance | Erythema and oedema |
| Tay et al. | 2008 | 9 | 2.d | Minimally ablative Er:YAG laser | Mild to moderate improvement was noted in all patients | Pain, erythema, peeling and crusting |
| Trelles et al. | 2014 | 19 | 2.d | Fractional ablative microplasma RF combined with acoustic pressure ultrasound (US) | Back and shoulder scars: mean score improved from 3.15 to 1.77 (P < 0.0001); Facial scars: mean score improved from 3.64 to 1.89 (P < 0.0001) (based on a 6-point scoring method) | Pain, prickling sensation, erythema, oedema and crusting |
| Vejjabhinanta et al. | 2014 | 26 | 2.d | FRM | Excellent improvement in scar appearance in 8% of patients, good in 23%, fair in 36.5%, and slight in 32.5% | Pain, oedema, erythema, scabbing and pigmentary changes |
| Verner et al. | 2016 | 12 | 2.d | Fractional bipolar RF | All patients achieved very good improvement in appearance | Discomfort, erythema, oedema and crusting |
| Walgrave et al. | 2009 | 30 | 2.d | Fractional CO2 laser | Surface texture improved by 1.63 ± 0.85; Atrophy improved by 1.09 ± 0.82; Overall scar appearance by 1.73 ± 0.84 (based on a 4-point scoring method) | Pain, oozing, punctate bleeding, erythema, oedema and hyperpigmentation |
| Wang et al. | 2013 | 37 | 2.d | IPL followed by fractional CO2 laser | Scar appearance improved slightly, but non-significantly (P > 0.05) after IPL, whereas it improved significantly after CO2 treatment (P < 0.05) | Pain, comedone and pustule formation, and erythema |
| Yeung et al. | 2012 | 20 | 2.d | Non-ablative fractional diode laser combined with bipolar RF | Mean reduction in scarring of 29% | Pain, erythema, oedema and hyperpigmentation |
| Yoo et al. | 2009 | 16 | 2.d | Non-ablative fractional erbium laser | Overall scar improvement: > 75% in 25% of patients, 51–75% in 38%, 25–50% in 25%, 0–25% in 13% | Erythema and oedema |
Joanna Briggs Institute classification.
Discussion
The ablative fractional CO2 laser was identified as the modality with the most available evidence (20 studies), followed by the Er:Glass laser and RF (18 and 13 studies, respectively). Interestingly, no studies in this review were found to have used fully ablative, non-fractional CO2 lasers.
A critical review of the existing studies shows that CO2 ablative fractional resurfacing (AFR) achieved improvement in appearance that ranged from modest to excellent in most of the studies. Rolling and boxcar scars were found to respond the best while ice-pick scars responded the least.48 Interestingly, combining the CO2 laser with punch elevation was found to be beneficial against such deeper scars.11
The efficacy of the CO2 laser was synergistic to treatment with the Nd:YAG laser.17 However, complementary use of platelet rich plasma (PRP) yielded contradictory results across different studies.13,15
In direct comparison, CO2 laser AFR was found to be superior to both Er:Glass FP and TCA CROSS.14,16
The risk of developing hyperpigmentation was heavily influenced by treatment parameters, with more aggressive regimes causing hyperpigmentation in as high as 55–100% of patients.18 This risk can, however, be brought down further by employing a number of different interventions. These include using lower treatment densities and pulsed energies, avoiding sun exposure and using broad-spectrum sunblock, and utilising pre-treatment bleaching agents.18 Lengthening the treatment interval was theorised to lead to fewer adverse effects; however, this was not demonstrated in practice.19
Er:Glass FP is commonly employed for multiple cosmetic purposes, including the treatment of rhytides, stretch marks and melasma.36 It is also widely used against acne scarring with moderate efficacy. More specifically, much better results can be achieved against boxcar and rolling scars, than against ice-pick scars.54 Even though comparison FP and the TCA CROSS method achieved similar outcomes, closer scrutiny reveals that FP is more effective against rolling scars, whereas the CROSS method has a better effect against ice-pick scars.20,21 This is likely due to the fact that ice pick scars are deep and the thermal effect of FP cannot reach their base in order to induce stimulation of the dermis and lead to collagen remodelling.21
Overall, results were comparable to those achieved by RF. However, FP is associated with higher levels of procedural discomfort.8 Other adverse reactions are mild and of short duration and can be further reduced by employing lower energy densities.33
RF energy, unlike lasers, is not absorbed by melanin, making this modality potentially safer in individuals with dark skin.30,55
In general, RF achieved moderate results and was found to be more effective against ice-pick than other types of scars.53 However, treatment was particularly effective when combined with certain other modalities such as acoustic pressure ultrasound, Er:YAG, diode and CO2 lasers.8,24,30
Overall, the main advantage of the RF modalities is their low profile of side effects, especially that of hyperpigmentation, and the low downtime associated with their use.51,53
Even though no direct comparison with FRM is available, efficacy seems to be better against rolling and boxcar type scars.9 Results seem to be inferior to those achieved by ablative resurfacing, and comparable but slightly inferior to those achieved by FP.1
Combined treatment with FRM and sublative fractional radiofrequency lead to excellent outcomes with apparent synergistic effects between the two modalities, while maintaining a safe profile.10
Because FRM affects a smaller fraction of the epidermis than most lasers (5% in FRM vs. 10–70% in FP), it was also associated with milder pain, lesser frequency and extent of hyperpigmentation, and shorter downtime.1 Therefore, FRM may be a good option in patients who are sensitive to pain, those at risk of hyperpigmentation (darker skin phototypes or prior history of post-procedural hyperpigmentation) or those who prefer a shorter downtime.1,9
The long-pulsed Nd:YAG achieved moderate efficacy against atrophic acne scars, mainly superficial boxcar and rolling scars, with measurable and statistically significant increase in the number of collagen fibres.28,35,46 Combination treatment with the Nd:YAG and PDL lasers leads to synergistic effects.28
The picosecond laser is a promising modality in this field. Unfortunately, small numbers of patients were treated with this laser as only one study utilised a 755-nm picosecond laser with a diffractive lens array. Results showed a 25–50% improvement against rolling type scars with minimal pain, little downtime and no pigmentary changes.37
The efficacy of the non-ablative diode in isolation has been found to be low against acne scars while also leading to significant discomfort (especially in those with darker skin).24,31
Even though the efficacy improved when treatment was combined with RF, it is unclear whether any synergistic effects were manifested.24,55,62
The ablative YSGG laser achieved excellent improvement in appearance, in the range of 40–90%. However, given the small numbers of patients treated with this device, it is hard to judge the place of this modality in the overall treatment pathway of acne scars. Further studies are required to reach more conclusive results.
The plasma skin regeneration system (PRS) has been advocated as an alternative to ablative and fractional resurfacing lasers. It utilises RF in order to convert nitrogen gas into plasma. The plasma is then directed onto the skin via a hand-piece, delivering thermal energy in a precise manner.43 Efficacy against acne scars was found to be moderate.
Benefits of this device include a lower cost, better safety and shorter downtime than ablative devices, and less training required for the operator.43 It is also worth noting that significant discomfort and hyperpigmentation are potential drawbacks to its use.43
One of the main problems of reviews in this field lies in the difficulty of comparing outcomes. Although several different grading systems have been proposed to standardise acne scar classification and evaluation, there is no universal accepted scale. Similarly, there is no widely accepted device for measuring acne scar improvement in a reproducible and objective fashion. The lack of such standardisation has led to great variability in evaluation and interpretation of data across different studies.37,54
Another important drawback lies in failing to identify the type of atrophic scar being treated. The depth of penetration of most lasers seems appropriate to ameliorate most superficial and some deeper scars (rolling and boxcar scars); however, ice-pick scars extend vertically to the deep dermis or subcutaneous tissue and are likely deeper than the depth that can be reached with conventional lasers.54 Because acne scars are usually a mix of ice-pick, boxcar and rolling scars, the final effect of fractional lasers would likely depend more on the predominant scars than on the fractional laser being used.54
Conclusions
Multiple devices have been used with varying levels of efficacy and very different safety profiles.
There is an overall lack of high-quality evidence about the effects of different interventions because of poor methodology, underpowered studies and different scarring subtypes being assessed. Furthermore, no standardised scale is available for acne scarring, leading to variability in evaluation and interpretation of data in different studies.
Ablative lasers seem to achieve the highest degree of efficacy among all devices tested, albeit this is associated with significant pain and downtime, and the risk for long-term pigmentary changes. Non-ablative FP has a much safer profile but does not achieve as good cosmetic results. The efficacy of FRM and RF is slightly inferior to that of FP but offers an even safer adverse profile. Little evidence is available on the remaining devices, with larger studies required to reach more solid conclusions.
Footnotes
Declaration of conflicting interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
ORCID iD: Georgios Kravvas
https://orcid.org/0000-0002-1924-0149
References
- 1. Chae WS, Seong JY, Jung HN, et al. Comparative study on efficacy and safety of 1550 nm Er:Glass fractional laser and fractional radiofrequency microneedle device for facial atrophic acne scar. J Cosmet Dermatol 2015; 14(2): 100–106. [DOI] [PubMed] [Google Scholar]
- 2. Cachafeiro T, Escobar G, Maldonado G, et al. Comparison of nonablative fractional erbium laser 1,340 nm and microneedling for the treatment of atrophic acne scars: a randomized clinical trial. Dermatol Surg 2016; 42(2): 232–241. [DOI] [PubMed] [Google Scholar]
- 3. Kravvas G, Al-Niaimi F. A systematic review of treatments for acne scarring. Part 1: Non-energy-based techniques. Scars, Burns & Healing 2017; 3: 2059513117695312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Goodman GJ. Treatment of acne scarring. In: Zouboulis Christos C, Katsambas Andreas D, Kligman Albert M. (eds) Pathogenesis and Treatment of Acne and Rosacea. Heidelberg: Springer Berlin, 2014: 527–536. [Google Scholar]
- 5. Alster TS, Tanzi EL, Lazarus M. The use of fractional laser photothermolysis for the treatment of atrophic scars. Dermatol Surg 2007; 33(3): 295–299. [DOI] [PubMed] [Google Scholar]
- 6. Goel A, Krupashankar DS, Aurangabadkar S, et al. Fractional lasers in dermatology–current status and recommendations. Indian J Dermatol Venereol Leprol 2011; 77(3): 369–379. [DOI] [PubMed] [Google Scholar]
- 7. Hedelund L, Moreau KER, Beyer DM, et al. Fractional nonablative 1,540-nm laser resurfacing of atrophic acne scars. A randomized controlled trial with blinded response evaluation. Lasers Med Sci 2010; 25(5): 749–754. [DOI] [PubMed] [Google Scholar]
- 8. Rongsaard N, Rummaneethorn P. Comparison of a fractional bipolar radiofrequency device and a fractional erbium-doped glass 1,550-nm device for the treatment of atrophic acne scars: a randomized split-face clinical study. Dermatol Surg 2014; 40(1): 14–21. [DOI] [PubMed] [Google Scholar]
- 9. Chandrashekar BS, Sriram R, Mysore R, et al. Evaluation of microneedling fractional radiofrequency device for treatment of acne scars. J Cutan Aesthet Surg 2014; 7(2): 93–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Park JY, Lee EG, Yoon MS, et al. The efficacy and safety of combined microneedle fractional radiofrequency and sublative fractional radiofrequency for acne scars in Asian skin. J Cosmet Dermatol 2016; 15(2): 102–107. [DOI] [PubMed] [Google Scholar]
- 11. Faghihi G, Nouraei S, Asilian A, et al. Efficacy of punch elevation combined with fractional carbon dioxide laser resurfacing in facial atrophic acne scarring: a randomized split-face clinical study. Indian J Dermatol 2015; 60(5): 473–478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Zhang Z, Fei Y, Chen X, et al. Comparison of a fractional microplasma radio frequency technology and carbon dioxide fractional laser for the treatment of atrophic acne scars: a randomized split-face clinical study. Dermatol Surg 2013; 39(4): 559–566. [DOI] [PubMed] [Google Scholar]
- 13. Gawdat HI, Hegazy RA, Fawzy MM, et al. Autologous platelet rich plasma: topical versus intradermal after fractional ablative carbon dioxide laser treatment of atrophic acne scars. Dermatol Surg 2014; 40(2): 152–161. [DOI] [PubMed] [Google Scholar]
- 14. Ahmed R, Mohammed G, Ismail N, et al. Randomized clinical trial of CO2 LASER pinpoint irradiation technique versus chemical reconstruction of skin scars (CROSS) in treating ice pick acne scars. J Cosmet Laser Ther 2014; 16(1): 8–13. [DOI] [PubMed] [Google Scholar]
- 15. Faghihi G, Keyvan S, Asilian A, et al. Efficacy of autologous platelet-rich plasma combined with fractional ablative carbon dioxide resurfacing laser in treatment of facial atrophic acne scars: A split-face randomized clinical trial. Indian J Dermatol Venereol Leprol 2016; 82(2): 162–168. [DOI] [PubMed] [Google Scholar]
- 16. Cho SB, Lee SJ, Cho S, et al. Non-ablative 1550-nm erbium-glass and ablative 10 600-nm carbon dioxide fractional lasers for acne scars: a randomized split-face study with blinded response evaluation. J Eur Acad Dermatol Venereol 2010; 24(8): 921–925. [DOI] [PubMed] [Google Scholar]
- 17. Kim S, Cho KH. Clinical trial of dual treatment with an ablative fractional laser and a nonablative laser for the treatment of acne scars in Asian patients. Dermatol Surg 2009; 35(7): 1089–1098. [DOI] [PubMed] [Google Scholar]
- 18. Yuan XH, Zhong SX, Li SS. Comparison study of fractional carbon dioxide laser resurfacing using different fluences and densities for acne scars in Asians: a randomized split-face trial. Dermatol Surg 2014; 40(5): 545–552. [DOI] [PubMed] [Google Scholar]
- 19. Bjørn M, Stausbøl-Grøn B, Braae Olesen A, et al. Treatment of acne scars with fractional CO2 laser at 1-month versus 3-month intervals: an intra-individual randomized controlled trial. Lasers Surg Med 2014; 46(2): 89–93. [DOI] [PubMed] [Google Scholar]
- 20. Leheta TM, Abdel Hay RM, Hegazy RA, et al. Do combined alternating sessions of 1540 nm nonablative fractional laser and percutaneous collagen induction with trichloroacetic acid 20% show better results than each individual modality in the treatment of atrophic acne scars? A randomized controlled trial. J Dermatolog Treat 2014; 25(2): 137–141. [DOI] [PubMed] [Google Scholar]
- 21. Kim HJ, Kim TG, Kwon YS, et al. Comparison of a 1,550 nm Erbium: glass fractional laser and a chemical reconstruction of skin scars (CROSS) method in the treatment of acne scars: a simultaneous split-face trial. Lasers Surg Med 2009; 41(8): 545–549. [DOI] [PubMed] [Google Scholar]
- 22. Yang Q, Huang W, Qian H, et al. Efficacy and safety of 1550-nm fractional laser in the treatment of acne scars in Chinese patients: A split-face comparative study. J Cosmet Laser Ther 2016; 18(6): 312–316. [DOI] [PubMed] [Google Scholar]
- 23. Alexis AF, Coley MK, Nijhawan RI, et al. Nonablative fractional laser resurfacing for acne scarring in patients with fitzpatrick skin phototypes IV-VI. Dermatol Surg 2016; 42(3): 392–402. [DOI] [PubMed] [Google Scholar]
- 24. Min S, Park SY, Moon J, et al. Comparison between Er:YAG laser and bipolar radiofrequency combined with infrared diode laser for the treatment of acne scars: Differential expression of fibrogenetic biomolecules may be associated with differences in efficacy between ablative and non-ablative laser treatment. Lasers Surg Med 2017; 49(4): 341–347. [DOI] [PubMed] [Google Scholar]
- 25. Mahmoud BH, Srivastava D, Janiga JJ, et al. Safety and efficacy of erbium-doped yttrium aluminum garnet fractionated laser for treatment of acne scars in type IV to VI skin. Dermatol Surg 2010; 36(5): 602–609. [DOI] [PubMed] [Google Scholar]
- 26. Wanitphakdeedecha R, Manuskiatti W, Siriphukpong S, et al. Treatment of punched-out atrophic and rolling acne scars in skin phototypes III, IV, and V with variable square pulse erbium:yttrium-aluminum-garnet laser resurfacing. Dermatol Surg 2009; 35(9): 1376–1383. [DOI] [PubMed] [Google Scholar]
- 27. Min S, Park SY, Yoon JY, et al. Comparison of fractional microneedling radiofrequency and bipolar radiofrequency on acne and acne scar and investigation of mechanism: comparative randomized controlled clinical trial. Arch Dermatol Res 2015; 307(10): 897–904. [DOI] [PubMed] [Google Scholar]
- 28. Min SU, Choi YS, Lee DH, et al. Comparison of a long-pulse Nd:YAG laser and a combined 585/1,064-nm laser for the treatment of acne scars: a randomized split-face clinical study. Dermatol Surg 2009; 35(11): 1720–1727. [DOI] [PubMed] [Google Scholar]
- 29. Phothong W, Wanitphakdeedecha R, Sathaworawong A, et al. High versus moderate energy use of bipolar fractional radiofrequency in the treatment of acne scars: a split-face double-blinded randomized control trial pilot study. Lasers Med Sci 2016; 31(2): 229–234. [DOI] [PubMed] [Google Scholar]
- 30. Cameli N, Mariano M, Serio M, et al. Preliminary comparison of fractional laser with fractional laser plus radiofrequency for the treatment of acne scars and photoaging. Dermatol Surg 2014; 40(5): 553–561. [DOI] [PubMed] [Google Scholar]
- 31. Uebelhoer NS, Bogle MA, Dover JS, et al. Comparison of stacked pulses versus double-pass treatments of facial acne with a 1,450-nmlaser. Dermatol Surg 2007; 33(5): 552–559. [DOI] [PubMed] [Google Scholar]
- 32. Alajlan AM, Alsuwaidan SN. Acne scars in ethnic skin treated with both non-ablative fractional 1,550 nm and ablative fractional CO2 lasers: comparative retrospective analysis with recommended guidelines. Lasers Surg Med 2011; 43(8): 787–791. [DOI] [PubMed] [Google Scholar]
- 33. Chan NP, Ho SG, Yeung CK, et al. The use of non-ablative fractional resurfacing in Asian acne scar patients. Lasers Surg Med 2010; 42(10): 710–715. [DOI] [PubMed] [Google Scholar]
- 34. Kim HW, Chang SE, Kim JE, et al. The safe delivery of fractional ablative carbon dioxide laser treatment for acne scars in Asian patients receiving oral isotretinoin. Dermatol Surg 2014; 40(12): 1361–1366. [DOI] [PubMed] [Google Scholar]
- 35. Badawi A, Tome MA, Atteya A, et al. Retrospective analysis of non-ablative scar treatment in dark skin types using the sub-millisecond Nd:YAG 1,064 nm laser. Lasers Surg Med 2011; 43(2): 130–136. [DOI] [PubMed] [Google Scholar]
- 36. Bencini PL, Tourlaki A, Galimberti M, et al. Nonablative fractional photothermolysis for acne scars: clinical and in vivo microscopic documentation of treatment efficacy. Dermatol Ther 2012; 25(5): 463–467. [DOI] [PubMed] [Google Scholar]
- 37. Brauer JA, Kazlouskaya V, Alabdulrazzaq H, et al. Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring. JAMA Dermatol 2015; 151(3): 278–284. [DOI] [PubMed] [Google Scholar]
- 38. Chan NP, Ho SG, Yeung CK, et al. Fractional ablative carbon dioxide laser resurfacing for skin rejuvenation and acne scars in Asians. Lasers Surg Med 2010; 42(9): 615–623. [DOI] [PubMed] [Google Scholar]
- 39. Chapas AM, Brightman L, Sukal S, et al. Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing. Lasers Surg Med 2008; 40(6): 381–386. [DOI] [PubMed] [Google Scholar]
- 40. Cho SB, Lee JH, Choi MJ, et al. Efficacy of the fractional photothermolysis system with dynamic operating mode on acne scars and enlarged facial pores. Dermatol Surg 2009; 35(1): 108–114. [DOI] [PubMed] [Google Scholar]
- 41. Chrastil B, Glaich AS, Goldberg LH, et al. Second-generation 1,550-nm fractional photothermolysis for the treatment of acne scars. Dermatol Surg 2008; 34(10): 1327–1332. [DOI] [PubMed] [Google Scholar]
- 42. Engın B, Kutlubay Z, Karakuş Ö, et al. Evaluation of effectiveness of erbium:yttrium-aluminum-garnet laser on atrophic facial acne scars with 22-MHz digital ultrasonography in a Turkish population. J Dermatol 2012; 39(12): 982–988. [DOI] [PubMed] [Google Scholar]
- 43. Gonzalez MJ, Sturgill WH, Ross EV, et al. Treatment of acne scars using the plasma skin regeneration (PSR) system. Lasers Surg Med 2008; 40(2): 124–127. [DOI] [PubMed] [Google Scholar]
- 44. Hu S, Hsiao WC, Chen MC, et al. Ablative fractional erbium-doped yttrium aluminum garnet laser with coagulation mode for the treatment of atrophic acne scars in Asian skin. Dermatol Surg 2011; 37(7): 939–944. [DOI] [PubMed] [Google Scholar]
- 45. Hwang YJ, Lee YN, Lee YW, et al. Treatment of acne scars and wrinkles in asian patients using carbon-dioxide fractional laser resurfacing: its effects on skin biophysical profiles. Ann Dermatol 2013; 25(4): 445–453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Keller R, Belda Júnior W, Valente NY, et al. Nonablative 1,064-nm Nd:YAG laser for treating atrophic facial acne scars: histologic and clinical analysis. Dermatol Surg 2007; 33(12): 1470–1476. [DOI] [PubMed] [Google Scholar]
- 47. Kim S. Treatment of acne scars in Asian patients using a 2,790-nm fractional yttrium scandium gallium garnet laser. Dermatol Surg 2011; 37(10): 1464–1469. [DOI] [PubMed] [Google Scholar]
- 48. Majid I, Imran S. Fractional CO2 laser resurfacing as monotherapy in the treatment of atrophic facial acne scars. J Cutan Aesthet Surg 2014; 7(2): 87–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Nirmal B, Pai SB, Sripathi H, et al. Efficacy and safety of erbium-doped yttrium aluminium garnet fractional resurfacing laser for treatment of facial acne scars. Indian J Dermatol Venereol Leprol 2013; 79(2): 193–198. [DOI] [PubMed] [Google Scholar]
- 50. Omi T, Kawana S, Sato S, et al. Fractional CO2 laser for the treatment of acne scars. J Cosmet Dermatol 2011; 10(4): 294–300. [DOI] [PubMed] [Google Scholar]
- 51. Peterson JD, Palm MD, Kiripolsky MG, et al. Evaluation of the effect of fractional laser with radiofrequency and fractionated radiofrequency on the improvement of acne scars. Dermatol Surg 2011; 37(9): 1260–1267. [DOI] [PubMed] [Google Scholar]
- 52. Petrov A, Pljakovska V. Fractional carbon dioxide laser in treatment of acne scars. Open Access Maced J Med Sci 2016; 4(1): 38–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Ramesh M, Gopal M, Kumar S, et al. Novel technology in the treatment of acne scars: the matrix-tunable radiofrequency technology. J Cutan Aesthet Surg 2010; 3(2): 97–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Sardana K, Manjhi M, Garg VK, et al. Which type of atrophic acne scar (ice-pick, boxcar, or rolling) responds to nonablative fractional laser therapy? Dermatol Surg 2014; 40(3): 288–300. [DOI] [PubMed] [Google Scholar]
- 55. Taub AF, Garretson CB. Treatment of acne scars of skin types II to V by sublative fractional bipolar radiofrequency and bipolar radiofrequency combined with diode laser. J Clin Aesthet Dermatol 2011; 4(10): 18–27. [PMC free article] [PubMed] [Google Scholar]
- 56. Tay YK, Kwok C. Minimally ablative erbium:YAG laser resurfacing of facial atrophic acne scars in Asian skin: a pilot study. Dermatol Surg 2008; 34(5): 681–685. [DOI] [PubMed] [Google Scholar]
- 57. Trelles MA, Martínez-Carpio PA. Attenuation of acne scars using high power fractional ablative unipolar radiofrequency and ultrasound for transepidermal delivery of bioactive compounds through microchannels. Lasers Surg Med 2014; 46(2): 152–159. [DOI] [PubMed] [Google Scholar]
- 58. Vejjabhinanta V, Wanitphakdeedecha R, Limtanyakul P, et al. The efficacy in treatment of facial atrophic acne scars in Asians with a fractional radiofrequency microneedle system. J Eur Acad Dermatol Venereol 2014; 28(9): 1219–1225. [DOI] [PubMed] [Google Scholar]
- 59. Verner I. Clinical evaluation of the efficacy and safety of fractional bipolar radiofrequency for the treatment of moderate to severe acne scars. Dermatol Ther 2016; 29(1): 24–27. [DOI] [PubMed] [Google Scholar]
- 60. Walgrave SE, Ortiz AE, MacFalls HT, et al. Evaluation of a novel fractional resurfacing device for treatment of acne scarring. Lasers Surg Med 2009; 41(2): 122–127. [DOI] [PubMed] [Google Scholar]
- 61. Wang B, Wu Y, Luo YJ, et al. Combination of intense pulsed light and fractional CO(2) laser treatments for patients with acne with inflammatory and scarring lesions. Clin Exp Dermatol 2013; 38(4): 344–351. [DOI] [PubMed] [Google Scholar]
- 62. Yeung CK, Chan NP, Shek SY, et al. Evaluation of combined fractional radiofrequency and fractional laser treatment for acne scars in Asians. Lasers Surg Med 2012; 44(8): 622–630. [DOI] [PubMed] [Google Scholar]
- 63. Yoo KH, Ahn JY, Kim JY, et al. The use of 1540 nm fractional photothermolysis for the treatment of acne scars in Asian skin: a pilot study. Photodermatol Photoimmunol Photomed 2009; 25(3): 138–142. [DOI] [PubMed] [Google Scholar]
How to cite this article
- Kravvas G, Al-Niaimi F. A systematic review of treatments for acne scarring. Part 2: Energy-based techniques. Scars, Burns & Healing, Volume 4, 2018. DOI: 10.1177/2059513118793420 [DOI] [PMC free article] [PubMed] [Google Scholar]
